Inframammary Segment has the Largest Share of Technology in the Middle East and Africa Breast Reconstruction Market during 2021–2028

According to a new market research study on “Middle East and Africa Breast Reconstruction Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Technology, Type, Placement and Procedure,” is expected to reach US$ 34.8 million by 2028 from US$ 25.8 million in 2021. The market is estimated to grow at a CAGR of 4.3% from 2021 to 2028. The report provides trends prevailing in the Middle East and Africa breast reconstruction market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the high prevalence of breast cancer and new product launches and FDA approvals are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the low awareness regarding reimbursement policies.

Countries in the Middle East have also extensively affected the socio-economic situation by the COVID–19 pandemic. However, the countries have sensibly responded to the COVID–19 pandemic to avoid the spread of disease. Similar to other countries, lockdown and social distancing were imposed, which has impaired these trends hindering access to work, regular income, fairs, payments, schools, and healthcare. Therefore, it is anticipated the nations have undergone tremendous losses and are still working to recover them. In addition, the lockdown has widely affected the non-emergency medical services in the region, which has somehow affected the aesthetic sectors. Countries like Saudi Arabia and UAE are developing as breast surgery destinations in the areas. However, they are dependent on the nations for the resources; therefore, the aesthetic industry has faced a negative impact and is expected to experience the same in the following few years.

The market for breast reconstruction market is segmented into technology, type, placement, and procedure. Based on technology, the breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical. In 2020, the inframammary by technology segment accounted for the largest share of the market. Growth of this segment is attributed to rising emphasis on aesthetic appearance and rising number of product launches. However, peri-areolar technology segment is estimated to register the highest CAGR during the forecast period.

Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, Establishment Labs S.A., and Groupe Sebbin SAS are among the leading companies in the Middle East and Africa breast reconstruction market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2020, AbbVie announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.

The report segments the Middle East and Africa Breast Reconstruction market as follows:

By Technology

• Inframammary
• Peri-Areolar
• Trans-Axillary
• Transumbilical

By Type

• Breast Implants
• Implant’s accessories

By Placement

• Dual Plane Insertion
• Subglandular Insertion
• Submuscular Insertion

By Procedure

• Immediate Procedures
• Delayed Procedures
• Revision Procedures

By Country

• Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa